Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Herein, we review the epitope approach to vaccine development, and discuss how knowledge of HLA supertypes might be used as a tool in the development of such vaccines. After reviewing the main structural features of the A2-, A3-, B7-, and B44- supertype alleles, and biological data demonstrating their immunological relevance, we analyze the frequency at which these supertype alleles are expressed in various ethnicities and discuss the relevance of those observations to vaccine development. Next, the existence of five new supertypes (A1, A24, B27, B58, and B62) is reported. As a result, it is possible to account for the predominance of all known HLA class I with only nine main functional binding specificities. The practical implications of this finding, as well as its relevance to understanding the functional implication of MHC polymorphism in humans, are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individual HLA-I alleles are classified into 12 discrete supertypes (52, 53), on the basis of similar peptide-anchor–binding specificities (26, 52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [52]
In the citing paper
“These supertypes together cover most HLA-A and HLA-B alleles found in distinct populations (52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [52]
Citations
Cites
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411 · cited 5×
“Independent observations demonstrate that the motif of the mouse class I allele L is identical to the B7-supermotif (Corr et al. 1992; Falk et al. 1991) While the necessary task of fully exploring and cataloging MHC polymorphism continues, we have begun to appreciate the common denominators and similarities hidden wit…”
BackgroundInfluentialRosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183 · cited 4×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundInfluentialGoulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgana, B., Edwards, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-212 · Cited by 1,116 · cited 1×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundRefined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution
Saper, M. A., Bjorkman, P. J., & Wiley, D. C. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90567-p · Cited by 1,077 · cited 2×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains (Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundMethodThe Biochemistry and Cell Biology of Antigen Processing and Presentation
Germain, R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.403 · Cited by 1,020 · cited 1×
“The complex of a major histocompatibilty complex (MHC) molecule and a peptidic antigen acts as the ligand recognized by MHC-restricted T cells (Garcia et al. 1999; Germain and Margulies 1993; Yewdell and Bennink 1999).”
BackgroundCrystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2K b
Fremont, D. H., Matsumura, M., Stura, E. A., Peterson, P. A., & Wilson, L. A. (1992) · Science · doi:10.1126/science.1323877 · Cited by 861 · cited 1×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains ( Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundSette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5586 · Cited by 830 · cited 1×
“…peptide-MHC binding have also been established (Engelhard 1994; Joyce and Natheson 1994; Sette and Grey 1992; Sidney et al. 1998), and the threshold of affinity associated with generation of immune responses has also been elucidated (Schaeffer et al. 1989; Sette et al. 1994; Southwood et al. 1998).”
BackgroundSelf-citationIdentification of self peptides bound to purified HLA-B27
Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R., & Wiley, D. C. (1991) · Nature · doi:10.1038/353326a0 · Cited by 827 · cited 5×
“Pool sequencing motifs for peptides bound to HLAB*1401-02, B*1503, B*1509, B*1510, B*1518, B*380102, B*3901, B*3902, B*3903-04, B*4801-02, B*7301, and B*2701-08 (Barber et al. 1996a, 1997; Boisgérault et al. 1996; DiBrino et al. 1994b; Falk et al. 1995c; Rötzschke et al. 1994; Garcia et al. 1997; Jardetzky et al. 1991…”
BackgroundInfluential
Cited by
Items 201–300 of 636
Virological, Immune and Host genetics Markers in the Control of HIV Infection
Mothe, B., Ibarrondo, J., Llano, A., & Brander, C. (2009) · Disease Markers · doi:10.1155/2009/360362 · Cited by 54
Sidney, J., Southwood, S., & Sette, A. (2005) · Immunogenetics · doi:10.1007/s00251-005-0004-2 · Cited by 45
“It has been speculated that A*2601 might be an A1-supertype molecule (Sette and Sidney 1999), although other studies have suggested that A*26 alleles would represent a separate supertype (Lund et al.”
BackgroundMethodResultSelf-citationCummings, A. L., Gukasyan, J., Lu, H. Y., Grogan, T., Sunga, G. M., Fares, C. M., Hornstein, N. J., Zaretsky, J. M., Carroll, J., Bachrach, B., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00140-1 · Cited by 47
Meyers, L. M., Gutiérrez, A. H., Boyle, C., Terry, F. E., McGonnigal, B., Salazar, A. Μ., Princiotta, M. F., Martin, W. D., Groot, A. S. D., & Moise, L. (2021) · npj Vaccines · doi:10.1038/s41541-021-00331-6 · Cited by 45
A framework to sub-type HLA supertypes
Kangueane, P. (2005) · Frontiers in bioscience · doi:10.2741/1582 · Cited by 44
Immunogenetic basis of HIV-1 infection, transmission and disease progression
Singh, P., Kaur, G., Sharma, G., & Mehra, N. K. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.012 · Cited by 44
Duquesnoy, R. J., Spellman, S. R., Haagenson, M. D., Wang, T., Horowitz, M. M., & Oudshoorn, M. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.07.001 · Cited by 44
“This includes the residues in the peptide-binding groove that are important in determining the repertoire of HLA bound peptides [28,32,33], the amino acids on the a1 and a2 helices that contact the TCR of alloreactive lymphocytes [34-37] and the HLA polymorphisms that 0% 20% 40% 60% 80% 100%”
Reche, P. A., Keskin, D. B., Hussey, R. E., Ancuța, P., Gabuzda, D. H., & Reinherz, E. L. (2006) · Medical Immunology · doi:10.1186/1476-9433-5-1 · Cited by 44
“alleles with similar peptide binding specificity [28]), e.”
BackgroundLong, D., Škoberne, M., Gierahn, T. M., Larson, S., Price, J., Clemens, V., Baccari, A., Cohane, K. P., Garvie, D., Siber, G. R., et al. (2014) · Virology · doi:10.1016/j.virol.2014.07.018 · Cited by 45
“nine defined HLA class I supertypes among subjects representing each group (Sette and Sidney, 1999; Sidney et al., 2008).”
BackgroundKotturi, M. F., Botten, J., Sidney, J., Bui, H., Giancola, L., Maybeno, M., Babin, J., Oseroff, C., Pasquetto, V., Greenbaum, J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000695 · Cited by 43
“As only 2 HLA supertypes were investigated, it should be possible to achieve essentially 100% coverage by identifying epitopes restricted by additional supertypes, such as A01, A24, B07, and B44 [16,21].”
BackgroundSelf-citationEpitope specific T‐cell responses against influenza A in a healthy population
Savić, M., Dembinski, J. L., Kim, Y., Tunheim, G., Cox, R. J., Oftung, F., Peters, B., & Mjaaland, S. (2015) · Immunology · doi:10.1111/imm.12548 · Cited by 48
Hogan, K. T., Sutton, J. N., Chu, K. U., Busby, J., Shabanowitz, J., Hunt, D. F., & Slingluff, C. L. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0592-y · Cited by 42
Zhang, S., Liu, J., Cheng, H., Tan, S., Qi, J., Yan, J., & Gao, G. F. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.08.015 · Cited by 42
Sedegah, M., Kim, Y., Ganeshan, H. D., Huang, J., Belmonte, M., Abot, E. N., Banania, J. G., Farooq, F., McGrath, S. M., Peters, B., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-185 · Cited by 42
“motifs [31], and the majority of HLA alleles fit these supertypes [31-33].”
BackgroundSelf-citationJin, J., Liu, Z., Nasiri, A., Cui, Y., Louis, S., Zhang, A., Zhao, Y., & Hu, J. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26065 · Cited by 47
Axelsson‐Robertson, R., Weichold, F., Sizemore, D. R., Wulf, M., Skeiky, Y. A. W., Sadoff, J., & Maeurer, M. J. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03201.x · Cited by 41
Polymorphism, haplotype composition, and selection in the Mhc-DRB of wild baboons
Huchard, É., Weill, M., Cowlishaw, G., Raymond, M., & Knapp, L. A. (2008) · Immunogenetics · doi:10.1007/s00251-008-0319-x · Cited by 46
“Certain class I alleles have been found to recognize similar antigen motifs and were thus grouped into HLA supertypes (Delguercio et al. 1995; Sette and Sidney 1998; Sette and Sidney 1999; Sidney et al. 1996).”
BackgroundSegal, Y., Soltys, J. N., Clarkson, B. D. S., Howe, C. L., Irani, S. R., & Pittock, S. J. (2025) · Neuron · doi:10.1016/j.neuron.2024.12.006 · Cited by 41
Kaseke, C., Park, R. J.-H., Singh, N. K., Koundakjian, D., Bashirova, A. A., García-Beltrán, W. F., Mbah, O. C. T., Ma, J., Senjobe, F., Urbach, J. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109378 · Cited by 46
“The generation of 18 TAP-deficient mono-allelic HLA class-I cell lines allowed the cell-based stability assay to identify epitopes that provide coverage of >99% of the global population (Sette and Sidney, 1999; Sidney et al., 2008).”
BackgroundPrediction of supertype-specific HLA class I binding peptides using support vector machines
Zhang, G., Božić, I., Kwoh, C. K., August, J. T., & Brusić, V. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.12.011 · Cited by 40
“HLA alleles that share sequence similarity and that bind largely overlapping sets of peptides define HLA supertypes (Sette and Sidney, 1999; Doytchinova et al., 2004; Lund et al., 2004).”
BackgroundOvsyannikova, I. G., Ryan, J. E., Vierkant, R. A., Pankratz, V. S., Jacobson, R. M., & Poland, G. A. (2005) · Immunogenetics · doi:10.1007/s00251-005-0061-6 · Cited by 39
“…most frequent HLA-B7 supertype allele that can share a peptide-binding specificity of Pro in position 2 and hydrophobic aliphatic (Ala, Leu, Ile, Met, Val) or aromatic residues (Phe, Trp, or Tyr) at the carboxyl-terminus as B*3501-03, B*51, B*5301, and B*5401 alleles (Sette and Sidney 1998, 1999).”
BackgroundBlatnik, R., Mohan, N., Bonsack, M., Falkenby, L. G., Hoppe, S., Josef, K., Steinbach, A., Becker, S., Nadler, W. M., Ručević, M., et al. (2018) · PROTEOMICS · doi:10.1002/pmic.201700390 · Cited by 44
Sette, A., Sidney, J., Livingston, B. D., Dzuris, J. L., Crimi, C., Walker, C. M., Southwood, S., Collins, E. J., & Hughes, A. L. (2003) · Immunogenetics · doi:10.1007/s00251-002-0530-0 · Cited by 39
“B molecules could be classified in one of nine different “supertypes” on the basis of certain similarities in their peptide-binding specificity (Sette and Sidney 1999).”
InfluentialSelf-citationWilson, C. C., Newman, M. J., Livingston, B. D., MaWhinney, S., Forster, J. E., Scott, J., Schooley, R. T., & Benson, C. A. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00492-07 · Cited by 39
“Pre-ART CD4 nadirs were 100 cells/l for 27% of the patients, 101 to 500 cells/l for 63%, and 500 cells/l for the remaining 10%. Patients were HLA typed ( 31 ).”
BackgroundMorita, Y., Heike, Y., Kawakami, M., Miura, O., Nakatsuka, S., Ebisawa, M., Mori, S., Tanosaki, R., Fukuda, T., Kim, S., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21960 · Cited by 39
The MHC Motif Viewer: A Visualization Tool for MHC Binding Motifs
Rapin, N., Hoof, I., Lund, O., & Nielsen, M. (2010) · Current Protocols in Immunology · doi:10.1002/0471142735.im1817s88 · Cited by 41
“Of the more than 2000 known HLA class I alleles, for example, the binding specificity has been experimentally characterized for less than 5% (Rammensee et al., 1999; Sette et al., 2005).”
BackgroundUnderstanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective
Tan, A. T., Koh, S., Goh, V. J., & Bertoletti, A. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05385.x · Cited by 43
Sedegah, M., Kim, Y., Peters, B., McGrath, S. M., Ganeshan, H. D., Lejano, J., Abot, E. N., Banania, G. J., Belmonte, M., Sayo, R., et al. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-241 · Cited by 39
“Therefore, to reach nearly 100% coverage, particularly of sub-Saharan Africans, other epitopes restricted by the prevalent supertypes A03, A24, B07 and B58 need to be identified.”
BackgroundInfluentialSelf-citationImproving MHC binding peptide prediction by incorporating binding data of auxiliary MHC molecules
Zhu, S., Udaka, K., Sidney, J., Sette, A., Aoki-Kinoshita, K. F., & Mamitsuka, H. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl141 · Cited by 39
“…examine this novel idea for nonameric peptide binding prediction to 16 HLA-A molecules in four different supertypes with respect to several studies (Sette and Sidney, 1999; Lund et al ., 2004): A1 (HLA-A (cid:1) 0101, A (cid:1) 2601, A (cid:1) 2902, A (cid:1) 3002), A2 (A (cid:1) 0201, A (cid:1)…”
InfluentialSelf-citationTerajima, M., Cruz, J., Leporati, A. M., Demkowicz, W. E., Kennedy, J. S., & Ennis, F. A. (2006) · Human Immunology · doi:10.1016/j.humimm.2005.12.004 · Cited by 38
Tan, A. C. L., Deliyannis, G., Bharadwaj, M., Brown, L. E., Zeng, W., & Jackson, D. C. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.54 · Cited by 42
Development of Peptide Vaccines in Dengue
Reginald, K., Chan, Y., Plebanski, M., & Poh, C. L. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612823666170913163904 · Cited by 43
T cell allorecognition and MHC restriction—A case of Jekyll and Hyde?
Archbold, J. K., Ely, L. K., Kjer‐Nielsen, L., Burrows, S. R., Rossjohn, J., McCluskey, J., & Macdonald, W. A. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.05.018 · Cited by 50
Davis, J. E., & Moss, D. J. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00227.x · Cited by 37
Srithayakumar, V., Castillo, S., Rosatte, R. C., & Kyle, C. J. (2011) · Immunogenetics · doi:10.1007/s00251-010-0485-5 · Cited by 36
“Clustering alleles into supertypes was primarily developed in the context of vaccine design (Sette and Sidney 1999); therefore, the definition of supertypes based on sequence motifs at the PSS may be an incomplete representation of peptide binding.”
BackgroundCosta, M. E. M. D., Zaïdi, S., Scoazec, J., Droit, R., Lim, W. C., Marchais, A., Salmon, J., Cherkaoui, S., Morscher, R. J., Laurent, A. P., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05320-0 · Cited by 43
“HLA-I alleles were assigned to known supertypes based on the corresponding binding motif speci fi cities 22,23,60 – 62 .”
Lasso, P., Mesa, D., Cuéllar, A., Guzmán, F., Bolaños, N. I., Rosas, F., Velasco, V. M., Thomas, M. C., López, M. C., González, J. M., et al. (2010) · Parasite Immunology · doi:10.1111/j.1365-3024.2010.01206.x · Cited by 38
High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide
Blicher, T. H., Kastrup, J. S., Buus, S., & Gajhede, M. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905013090 · Cited by 37
“…the extraction of 9–12 (Lund et al., 2004; Sette & Sidney, 1999) supertypes out of the 975 different MHC-I A and B alleles (January 2005; see http://www.anthonynolan.org.uk/HIG/ index.html) and more than 99% of the world population carry at least one of these supertypes (Sette & Sidney, 1999).”
BackgroundDesign of multi-epitope, analogue-based cancer vaccines
Fikes, J. D., & Sette, A. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.6.985 · Cited by 36
“Our group has demonstrated that a large fraction of HLA class I molecules can be classified into a relatively few ‘HLA supertypes’, each characterised by largely overlapping peptide binding repertoires based on consensus structures of the main peptide binding pockets [26].”
BackgroundSelf-citationTian, Y., Antunes, R. D. S., Sidney, J., Arlehamn, C. S. L., Grifoni, A., Dhanda, S. K., Paul, S., Peters, B., Weiskopf, D., & Sette, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02778 · Cited by 38
Self-citationMarkiewicz, M. A., & Kast, W. M. (2004) · Cancer Investigation · doi:10.1081/cnv-200029072 · Cited by 42
“However, HLA supertypes have been identified, and it has been determined that it is possible to account for all known HLA class I with only nine main functional binding specificities.([47]) Therefore, the number of peptides that will need to be defined may be more limited than previously believed.”
BackgroundLazaro, E., Godfrey, S. B., Stamegna, P., Ogbechie, T., Kerrigan, C., Zhang, M., Walker, B. D., & Gall, S. L. (2009) · The Journal of Infectious Diseases · doi:10.1086/599837 · Cited by 34
“whereas peptides produced in monocyte extracts yielded shorter peptides compatible with MHC-I loading (8–11 mer) [39].”
BackgroundHertz, T., & Yanover, C. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-s1-s3 · Cited by 35
“Additionally, in MHC class I and MHC class II, many proteins are grouped into supertypes [17] (such as the HLA-A2 MHC class I supertype).”
BackgroundCross-Reactive CD8+ T Cell Epitopes Identified in US Adolescent Minorities
Sabbaj, S., Bansal, A., Ritter, G., Perkins, C., Edwards, B. H., Gough, E. K., Tang, J., Szinger, J. J., Korber, B., Wilson, C. M., et al. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200308010-00003 · Cited by 35
Computer‐aided design of T‐cell epitope‐based vaccines: addressing population coverage
Oyarzún, P., & Kobe, B. (2015) · International Journal of Immunogenetics · doi:10.1111/iji.12214 · Cited by 34
“HLA class I supertypes described by Sette & Sidney (1999) corresponded to nine groups covering most of the HLA-A and HLA-B polymorphisms.”
Zhang, G., Khan, A. M., Kellathur, S. N., Heiny, A. T., Lee, K. X., Kwoh, C. K., August, J. T., & Brusić, V. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-s1-s19 · Cited by 34
“The A2, A3 and B7 supertypes together cover approximately 88% of the human population [10,16], irrespective of ethnicity, while class II DR supertype is present in 100% of the population.”
BackgroundKohyama, S., Ohno, S., Suda, T., Taneichi, M., Yokoyama, S., Mori, M., Kobayashi, A., Hayashi, H., Uchida, T., & Matsui, M. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.004 · Cited by 36
“Sette and Sidney, 1999 defined only nine HLA class I supertypes that almost cover the entire repertoire of HLA class I molecules.”
BackgroundAspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma
Tomimaru, Y., Mishra, S., Safran, H. P., Charpentier, K. P., Martin, W. D., Groot, A. S. D., Gregory, S. H., & Wands, J. R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.037 · Cited by 39
Methodological advances in the design of peptide-based vaccines
Kalita, P., & Tripathi, T. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.03.004 · Cited by 37
Progress on adenovirus-vectored universal influenza vaccines
Xiang, K., Guan, Y., Yan, Z., Shanshan, Y., Zhang, L., Li, H., & Maosheng, S. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1016674 · Cited by 37
Synthetic peptides as cancer vaccines
Sundaram, R., Dakappagari, N. K., & Kaumaya, P. T. P. (2002) · Biopolymers · doi:10.1002/bip.10258 · Cited by 34
Meyer-Lucht, Y., Otten, C., Püttker, T., Pardini, R., Metzger, J. P., & Sommer, S. (2010) · Conservation Genetics · doi:10.1007/s10592-010-0093-9 · Cited by 37
“The technique was invented in human vaccine development studies and is supported by the fact that in humans different HLA alleles overlap in their peptide binding specifities (Southwood et al. 1998; Sette and Sidney 1999; Trachtenberg et al. 2003).”
MethodNatural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors
Bear, A. S., Nadler, R. B., O’Hara, M. H., Stanton, K. L., Xu, C. B., Saporito, R., Rech, A. J., Baroja, M. L., Blanchard, T., Elliott, M. H., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175790 · Cited by 38
Tan, P., Khan, A. M., & August, J. T. (2011) · Human Vaccines · doi:10.4161/hv.7.4.13845 · Cited by 37
Gupta, S. K., Smita, S., Sarangi, A. N., Srivastava, M., Akhoon, B. A., Rahman, Q., & Gupta, S. K. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.005 · Cited by 34
Rhesus Macaque MHC Class I Molecules Present HLA-B-Like Peptides
Hickman, H. D., Bardet, W., Gilb, A., Luis, A. D., Jackson, K. W., Watkins, D. I., & Hildebrand, W. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.367 · Cited by 33
Gupta, S. K., Srivastava, M., Akhoon, B. A., Smita, S., Schmitz, U., Wolkenhauer, O., Vera, J., & Gupta, S. K. (2010) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2010.10.013 · Cited by 33
Sette, A., Sidney, J., Bui, H., del Guercio, M., Alexander, J., Loffredo, J. T., Watkins, D. I., & Mothé, B. R. (2005) · Immunogenetics · doi:10.1007/s00251-004-0749-z · Cited by 33
“Mamu-A*11 peptide-binding specificity overlaps with those of H-2 Kk and the HLA B44-supertype The Mamu-A*11 peptide-binding specificity is similar to the motif recognized by other MHC molecules, such as those of the HLA B44-supertype (Sette and Sidney 1999).”
BackgroundResultSelf-citationHuman Leukocyte Antigen Class I Supertypes and HIV-1 Control in African Americans
Lazaryan, A., Song, W., Lobashevsky, E. S., Tang, J., Shrestha, S., Zhang, K., Gardner, L. I., McNicholl, J. M., Wilson, C. M., Klein, R. S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01962-09 · Cited by 36
“HLA class I alleles were grouped into four HLA-A and five HLA-B supertypes according to the framework of Sette and Sidney (38, 39), which served as a benchmark for most previous research on the role of HLA class I supertypes in HIV-1 infection.”
BackgroundMethodInfluentialTorikai, H., Akatsuka, Y., Miyazaki, M., Tsujimura, A., Yatabe, Y., Kawase, T., Nakao, Y., Tsujimura, K., Motoyoshi, K., MORISHIMA, Y., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06205.x · Cited by 33
Mizukoshi, E., Nascimbeni, M., Blaustein, J. B., Mihalik, K., Rice, C. M., Liang, T. J., Feinstone, S. M., & Rehermann, B. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6093-6103.2002 · Cited by 33
“, B-pocket residues 7 and 34 and F-pocket residues 73, 80, 81, 84, 118, 123, 143, 146, and 147 (20, 45), did not differ between the analyzed HLA and Patr molecules and are therefore not listed in this table.”
InfluentialBuseyne, F., & Rivière, Y. (2001) · International Immunology · doi:10.1093/intimm/13.7.941 · Cited by 33
Terajima, M., Orphin, L., Leporati, A. M., Pazoles, P., Cruz, J., Rothman, A. L., & Ennis, F. A. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.09.009 · Cited by 35
“categorized HLA-A and HLA-B alleles into HLA supertypes based on the similarity of binding peptides, which are called “supermotifs” [33-35].”
BackgroundMacDonald, K. S., Matukas, L. M., Embree, J. E., Fowke, K. R., Kimani, J., Nagelkerke, N. J. D., Oyugi, J. O., Kiama, P., Kaul, R., Luscher, M. A., et al. (2001) · Immunology Letters · doi:10.1016/s0165-2478(01)00277-2 · Cited by 32
McMahon, R. M., Friis, L. S., Siebold, C., Friese, M. A., Fugger, L. H., & Jones, E. Y. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911007888 · Cited by 36
Minami, T., Matsueda, S., Takedatsu, H., Tanaka, M., Noguchi, M., Uemura, H., Itoh, K., & Harada, M. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0216-9 · Cited by 31
“Among them, the A3 supertype alleles include the allelic products of at least Wve common HLA-A alleles, including A3, A11, A31, A33, and A68; these alleles are found in 38% of Caucasians, 53% of Chinese, 46% of Japanese, and 43% of North American African–Americans and Hispanics [ 20 ].”
BackgroundMethodInfluentialMueller, S. M., Schaetz, B., Eismann, K., Bergmann, S., Bäuerle, M., Schmitt-Haendle, M., Walter, H., Schmidt, B., Korn, K., Sticht, H., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01547-06 · Cited by 31
“Interestingly, we also found that cells from patients with HLA-B18 and HLA-B40, both belonging to the B44 supertype (39, 40), recognized several EW9 variants (data not shown).”
BackgroundThimme, R., Chang, K., Pemberton, J., Sette, A., & Chisari, F. V. (2001) · Journal of Virology · doi:10.1128/jvi.75.8.3984-3987.2001 · Cited by 31
“Degenerate immunogenicity is defined as the capacity of a single peptide to be immunogenic in the context of multiple HLA molecules (15).”
BackgroundSelf-citationBello, G., Casado, C., Sandonis, V., Alonso-Nieto, M., Vicario, J. L., García, S., Hernando, V., Rodríguez, C., del Romero, J., & López‐Galíndez, C. (2005) · Journal of General Virology · doi:10.1099/vir.0.80410-0 · Cited by 37
“Higher resolution by sequence-based typing was also used when needed in order to precisely define the HLA supertypes ( Sette & Sidney, 1999; Trachtenberg et al., 2003).”
MethodTakedatsu, H., Shichijo, S., Katagiri, K., Sawamizu, H., Sata, M., & Itoh, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0797-3 · Cited by 31
“On the other hand, based on the structural similarities of the group of HLA alleles and the peptide binding motif analysis, the following supertypes have been proposed, HLA-A2, -A3, -B7, and -B44 supertype alleles (11).”
BackgroundInfluentialT-Cell Immunity to Influenza A Viruses
Grant, E. J., Chen, L., Quiñones‐Parra, S. M., Pang, K. C., Kedzierska, K., & Chen, W. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013010019 · Cited by 36
A Multivalent Vaccination Strategy for the Prevention of Old World Arenavirus Infection in Humans
Botten, J., Whitton, J. L., Barrowman, P., Sidney, J., Whitmire, J. K., Alexander, J., Kotturi, M. F., Sette, A., & Buchmeier, M. J. (2010) · Journal of Virology · doi:10.1128/jvi.00672-10 · Cited by 30
“Because the epitopes in this study are HLA-A2 supertype restricted, they are capable of providing broad population coverage ( 43% of the population, regardless of ethnicity) (45).”
BackgroundSelf-citationSequence-structure-function relationships in class I MHC: A local frustration perspective
Serçinoğlu, O., & Özbek, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232849 · Cited by 37
Patterns of evolution of MHC class II genes of crows ( Corvus ) suggest trans-species polymorphism
Eimes, J. A., Townsend, A. K., Sepil, I., Nishiumi, I., & Satta, Y. (2015) · PeerJ · doi:10.7717/peerj.853 · Cited by 32
“For the analyses, we used five different nucleotide partitions as well as supertyping, which clusters functionally equivalent amino acid sequences into units of selection (Sette & Sidney, 1999; Lund et al., 2004; Sidney et al., 2008).”
BackgroundMethodThe changing field of vaccine development in the genomics era
Brusić, V., & August, J. T. (2004) · Pharmacogenomics · doi:10.1517/14622416.5.6.597 · Cited by 30
T-Cell Tolerance for Variability in an HLA Class I-Presented Influenza A Virus Epitope
Wahl, A., McCoy, W. H., Schafer, F. B., Bardet, W., Buchli, R., Fremont, D. H., & Hildebrand, W. H. (2009) · Journal of Virology · doi:10.1128/jvi.00932-09 · Cited by 30
T-Cell Epitope Prediction: Rescaling Can Mask Biological Variation between MHC Molecules
MacNamara, A., Kadolsky, U. D., Bangham, C. R. M., & Asquith, B. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000327 · Cited by 32
“Each epitope in SYF(1) was experimentally verified to bind to one of 10 MHC class I supertypes [32].”
BackgroundIdentifying the immune interactions underlying HLA class I disease associations
Debebe, J., Boelen, L., Lee, J. C., IAVI Protocol C Investigators, Sanders, E. J., Anzala, O., Kamali, A., Kaleebu, P., Karita, E., Kilembe, W., et al. (2020) · eLife · doi:10.7554/elife.54558 · Cited by 37
“Analysis of TCR.FS within and between supertypes An HLA class I supertype is a group of HLA class I alleles which have been identified to have similar peptide binding properties (Sette and Sidney, 1999; Sidney et al., 2008).”
BackgroundHLA Class I Supertype Classification Based on Structural Similarity
Shen, Y. L., Parks, J. M., & Smith, J. C. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200685 · Cited by 33
Contribution of HLA Class I Allele Expression to CD8+ T‐Cell Responses against Epstein–Barr Virus
Höllsberg, P. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.0300-9475.2001.01043.x · Cited by 29
Characteristics of HLA Class I and Class II Polymorphisms in Rwandan Women
Tang, J.-M., Naik, E., Costello, C., Karita, E., Rivers, C. A., Allen, S., & Kaslow, R. (2000) · Experimental and Clinical Immunogenetics · doi:10.1159/000019138 · Cited by 33
Harashima, N., Tanosaki, R., Shimizu, Y., Kurihara, K., Masuda, T., Okamura, J., & Kannagi, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.10088-10092.2005 · Cited by 29
Novel approaches in polyepitope T-cell vaccine development against HIV-1
Карпенко, Л. И., Bazhan, S. I., Антонец, Д., & Belyakov, I. M. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2014.861748 · Cited by 31
Ovsyannikova, I. G., Schaid, D. J., Larrabee, B. R., Haralambieva, I. H., Kennedy, R. B., & Poland, G. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171261 · Cited by 31
McKinney, D. M., Erickson, A. L., Walker, C. M., Thimme, R., Chisari, F. V., Sidney, J., & Sette, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4414 · Cited by 28
Self-citationTowards a Mathematical Foundation of Immunology and Amino Acid ChainsPreprint
Shen, W.-J., Wong, H., Xiao, Q.-W., Guo, X., & Smale, S. T. (2012) · arXiv (Cornell University) · doi:10.48550/arxiv.1205.6031 · Cited by 33
Advances of computational methods enhance the development of multi-epitope vaccines
Wei, Y., Qiu, T., Ai, Y., Zhang, Y., Xie, J., Zhang, D., Luo, X., Sun, X., Wang, X., & Qiu, J. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf055 · Cited by 40
VaxCelerate II: Rapid development of a self-assembling vaccine for Lassa fever
Leblanc, P. R., Moise, L., Luza, C., Chantaralawan, K., Lezeau, L., Yuan, J., Field, M. B., Richer, D., Boyle, C., Martin, W. D., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.34413 · Cited by 27
“Class I epitopes were identified from among 9mer and 10-mer peptides for 6 “supertype” alleles: A*0101, A*0201, A*0301, A*2402, B*0702, B*4401.(73) Lassa antigens were screened for regions of high Class II epitope density using the ClustiMer algorithm for construction of broadly reactive vaccine immunogens 15–25 amino…”
MethodHLA-A*33:01 as Protective Allele for Severe Dengue in a Population of Filipino Children
Mercado, E. S., Espino, F. E., Perez, M. L. M., Bilar, J. M., Bajaro, J. D. P., Huy, N. T., Baello, B. Q., Kikuchi, M., & Hirayama, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115619 · Cited by 27
“These aleles are grouped based on structural similarities and peptide binding motif analysis [35].”
BackgroundThe presentation of SARS-CoV-2 peptides by the common HLA-A∗02:01 molecule
Szeto, C. W., Chatzileontiadou, D. S. M., Nguyen, A., Sloane, H., Lobos, C. A., Jayasinghe, D., Halim, H., Smith, C., Riboldi‐Tunnicliffe, A., Grant, E. J., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102096 · Cited by 28
Groot, A. S. D., Einck, L., Moise, L., Chambers, M. J., Ballantyne, J. A., Malone, R. W., Ardito, M. T., & Martin, W. D. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.25611 · Cited by 27
Modeling the Repertoire of True Tumor-Specific MHC I Epitopes in a Human Tumor
Srivastava, N., & Srivastava, P. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006094 · Cited by 29
“Secondly, these rules have become clear only during the last 10–15 years [8,9,10].”
BackgroundBioinformatics for cancer immunotherapy target discovery
Olsen, L. R., Campos, B., Barnkob, M. B., Winther, O., Brusić, V., & Andersen, M. H. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1627-7 · Cited by 30
“For each class, several major and minor proteins are defined, which are in turn classified into supertypes [101, 102] and 9,310 individual alleles are reported in Release 3.”
BackgroundA CD8+ T Cell Heptaepitope Minigene Vaccine Induces Protective Immunity against Chlamydia pneumoniae
Pinchuk, I., STARCHER, B. C., Livingston, B. D., Tvninnereim, A., Wu, S., Appella, E., Sidney, J., Sette, A., & Wizel, B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5729 · Cited by 27
“A multiepitope-based anti-Cpn minigene vaccine could then for instance include three times the number of CD8 CTL epitopes present in CpnCTL7, and such epitopes could be chosen to represent at least the HLA-A2, -A3, and -B7 supertypes, which would provide recognition in nearly 90% of the global population, regardless o…”
BackgroundSelf-citationCharacterization of Host Immunity to cytomegalovirus pp150 (UL32)
Rosa, C. L., Wang, Z., Lacey, S. F., Markel, S., Sharma, M. C., Martinez, J., Lalimarmo, M. M., & Diamond, D. J. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.10.008 · Cited by 27
MHC–peptide specificity and T-cell epitope mapping: where immunotherapy starts
Provenzano, M., Panelli, M. C., D, S. M. M., Bracci, L., Sais, G., Stroncek, D. F., Spagnoli, G. C., & Marincola, F. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.08.008 · Cited by 27
Bucci, K., Kastens, W., Hollingdale, M. R., Shankar, A. H., Alpers, M. P., King, C. L., & Kazura, J. W. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01346.x · Cited by 27
Statistical deconvolution of enthalpic energetic contributions to MHC-peptide binding affinity
Davies, M. N., Hattotuwagama, C. K., Moss, D. S., Drew, M. G. B., & Flower, D. R. (2006) · BMC Structural Biology · doi:10.1186/1472-6807-6-5 · Cited by 27
“Typically, prediction techniques have been calibrated by using experimentally-determined IC50 and BL50 data [9], at least indirectly.”
Solomon, C., Southwood, S., Hoof, I., Rudersdorf, R. A., Peters, B., Sidney, J., Pinilla, C., Marcondes, M. C. G., Ling, B., Marx, P. A., et al. (2010) · Immunogenetics · doi:10.1007/s00251-010-0450-3 · Cited by 26
“On the contrary, these data indicate that HLA-B7 supertype specificity has arisen independently in humans and macaques, most likely as a result of convergent evolution (Sette and Sidney 1999).”
ResultSelf-citationSquires, K. D., Monajemi, M., Woodworth, C. F., Grant, M. D., & Larijani, M. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000689 · Cited by 26
“HLA-B57 is associated with slow progression, whereas B35 is associated with rapid progression in a manner that corresponds to their ability to present immunogenic peptides to HIV-specific CD8+ T cells.34–41 HLA-A2 and A3 were chosen because they are frequent in the population, and their ability to cross-present each o…”
Background
Metadata
- Authors
- Sette, A., & Sidney, J.
- ORCID
- Venue
- Immunogenetics
- Published
- 1999-11
- Volume
- 50
- Issue
- 3-4
- Pages
- 201-212
- ISSN
- 0093-7711 (ISSN-L)
- 1432-1211
- OpenAlex
- W2052321000
- Cited by
- 635
- References
- 115
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 19 · 2023: 18 · 2022: 16 · 2021: 21 · 2020: 25 · 2019: 14 · 2018: 20 · 2017: 19 · 2016: 14 · 2015: 26 · 2014: 26 · 2013: 27 · 2012: 37
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Immunogenetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01ai045241-010, n01ai095362-000)
- National Institute of Allergy and Infectious Diseases (N01 AI-45241, N01-AI-95362)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- HLA-A, HLA-B, MHC polymorphism
- MeSH terms
- Alleles, Amino Acid Sequence, Animals, Epitopes, Humans, Molecular Sequence Data, Polymorphism, Genetic, HLA-A Antigens, HLA-B Antigens, Histocompatibility Antigens Class I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.